The Insulin-like Growth Factor-1 (IGF-1) axis is a critical endocrine pathway primarily regulated by Growth Hormone (GH), linking the pituitary gland, the liver, and peripheral tissues. IGF-1 is a potent anabolic peptide hormone essential for cell proliferation, tissue growth, and repair, mediating many of the effects of GH throughout the body. Clinically, this axis is a key indicator of growth status, metabolic health, and biological aging.
Origin
This term originates from the study of growth factors and endocrinology, specifically defining the relationship between Growth Hormone and its primary effector molecule, IGF-1. The system is also known as the GH-IGF-1 axis.
Mechanism
Growth Hormone is released by the anterior pituitary and stimulates the liver to produce IGF-1. Circulating IGF-1 then acts on target cells by binding to the IGF-1 receptor, triggering intracellular signaling cascades that promote protein synthesis and inhibit apoptosis. The activity of this axis is tightly regulated by negative feedback, where IGF-1 can inhibit GH release, ensuring precise control over growth and metabolism.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.